2011年ADA诊疗指南英文原版,英文好的可以看原版
ExecutiveSummary:StandardsofMedicalCareinDiabetes—2011
Currentcriteriaforthediagnosisofdiabetes
●A1C 6.5%.Thetestshouldbeper-formedinalaboratoryusingamethodthatisNationalGlycohemoglobinStan-dardizationProgram(NGSP)-certi edandstandardizedtotheDiabetesCon-trolandComplicationsTrial(DCCT)assay
●fastingplasmaglucose(FPG) 126mg/dl(7.0mmol/l).Fastingisde nedasnocaloricintakeforatleast8h,or●2-hplasmaglucose 200mg/dl(11.1mmol/l)duringanoralglucosetoler-ancetest(OGTT).ThetestshouldbeperformedasdescribedbytheWorldHealthOrganization,usingaglucoseloadcontainingtheequivalentof75ganhydrousglucosedissolvedinwater●inapatientwithclassicsymptomsofhyperglycemiaorhyperglycemiccrisis,arandomplasmaglucose 200mg/dl(11.1mmol/l)
●intheabsenceofunequivocalhypergly-cemia,resultshouldbecon rmedbyrepeattesting.
Testingfordiabetesinasymptomaticpatients
●Testingtodetecttype2diabetesandassessriskforfuturediabetesinasymp-tomaticpeopleshouldbeconsideredinadultsofanyagewhoareoverweightorobese(BMI 25kg/m2)andwhohaveoneormoreadditionalriskfactorsfordiabetes(seeTable4ofthe“StandardsofMedicalCareinDiabetes—2011”).Inthosewithouttheseriskfactors,test-ingshouldbeginatage45years.(B)●Iftestsarenormal,repeattestingcar-riedoutatleastat3-yearintervalsisreasonable.(E)
●Totestfordiabetesortoassessriskoffuturediabetes,A1C,FPG,or2-h75-gOGTTareappropriate.(B)
●Inthoseidenti edwithincreasedriskforfuturediabetes,identifyand,ifap-propriate,treatothercardiovasculardisease(CVD)riskfactors.(B)Detectionanddiagnosisof
gestationaldiabetesmellitus(GDM)●Screenforundiagnosedtype2diabetesatthe rstprenatalvisitinthosewithriskfactors,usingstandarddiagnosticcriteria.(B)
●Inpregnantwomennotknowntohavediabetes,screenforGDMat24–28weeksofgestation,usinga75-g2-hOGTTandthediagnosticcutpointsinTable6ofthe“StandardsofMedicalCareinDiabetes—2011”.(B)
●ScreenwomenwithGDMforpersistentdiabetes6–12weekspostpartum.(E)●WomenwithahistoryofGDMshouldhavelifelongscreeningforthedevelop-mentofdiabetesorprediabetesatleastevery3years.(E)
Prevention/delayoftype2diabetesPatientswithimpairedglucosetoler-ance(IGT)(A),impairedfastingglu-cose(IFG)(E),oranA1Cof5.7–6.4%(E)shouldbereferredtoaneffectiveongoingsupportprogramtargetingweightlossof7%ofbodyweightandincreasingphysicalactivitytoatleast150min/weekofmoderateactivitysuchaswalking.
●Follow-upcounselingappearstobeim-portantforsuccess.(B)
●Basedonpotentialcost-savingsofdia-betesprevention,suchprogramsshouldbecoveredbythird-partypay-ors.(E)
●Metformintherapyforpreventionoftype2diabetesmaybeconsideredinthoseathighestriskfordevelopingdi-abetes,suchasthosewithmultipleriskfactors,especiallyiftheydemonstrateprogressionofhyperglycemia(e.g.A1C 6%)despitelifestyleinterventions.(B)
●Monitoringforthedevelopmentofdi-●
abetesinthosewithprediabetesshouldbeperformedeveryyear.(E)
Glucosemonitoring
●Self-monitoringofbloodglucose(SMBG)shouldbecarriedoutthreeormoretimesdailyforpatientsusingmul-tipleinsulininjectionsorinsulinpumptherapy.(A)
●Forpatientsusingless-frequentinsulininjections,non-insulintherapies,ormedicalnutritiontherapy(MNT)alone,SMBGmaybeusefulasaguidetothesuccessoftherapy.(E)
●Toachievepostprandialglucosetar-gets,postprandialSMBGmaybeappro-priate.(E)
●WhenprescribingSMBG,ensurethatpatientsreceiveinitialinstructionin,androutinefollow-upevaluationof,SMBGtechniqueandtheirabilitytousedatatoadjusttherapy.(E)
●Continuousglucosemonitoring(CGM)inconjunctionwithintensiveinsulinregimenscanbeausefultooltolowerA1Cinselectedadults(age 25years)withtype1diabetes.(A)
●AlthoughtheevidenceforA1C-loweringislessstronginchildren,teens,andyoungeradults,CGMmaybehelpfulinthesegroups.Successcor-relateswithadherencetoongoinguseofthedevice.(C)
●CGMmaybeasupplementaltooltoSMBGinthosewithhypoglycemiaun-awarenessand/orfrequenthypoglyce-micepisodes.(E)
A1C
●PerformtheA1Ctestatleasttwotimesayearinpatientswhoaremeetingtreat-mentgoals(andwhohavestableglyce-miccontrol).(E)
●PerformtheA1Ctestquarterlyinpa-tientswhosetherapyhaschangedorwhoarenotmeetingglycemicgoals.(E)●Useofpoint-of-caretestingforA1Cal-lowsfortimelydecisionsontherapychanges,whenneeded.(E)
●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
DOI:10.2337/dc11-S004
©2011bytheAmericanDiabetesAssociation.Readersmayusethisarticleaslongastheworkisproperlycited,theuseiseducationalandnotforpro t,andtheworkisnotaltered.Seedoc.guandang.net.
Glycemicgoalsinadults
LoweringA1Ctobeloworaround7%hasbeenshowntoreducemicrovascu-larandneuropathiccomplicationsof
care.diabetesjournals.org
S4DIABETESCARE,VOLUME34,SUPPLEMENT1,JANUARY2011
2011年ADA糖尿病诊疗指南(最新,完整,全英文版)_医学_高等教育_教育专区。ADA Standards of Medical Care 2011(2011年ADA糖尿病诊疗指南,最新,完整版,全英文,...
2011 年 ADA 糖尿病诊疗指南全网发布:2011-07-19 14:26 发表者:张昌丽 (访问人次:798) 糖尿病的诊断标准: HbA1C≥6.5%。试验应该用美国糖化血红蛋白标准...
2011 年 ADA 糖尿病诊疗指南目前糖尿病的诊断标准 ● A1C ≥ 6.5% 。试验应该用美国糖化血红蛋白标准化计划组织( National Glycohemoglobin Standardization Program,...
2011 年 ADA 糖尿病诊疗指南 2011 年 ADA 糖尿病诊疗标准执行纲要 美国糖尿病协会 王新军 于文 译 滨州医学院附属滨州市人民医院内分泌科,滨州,256610 目前...
2011年ADA糖尿病诊疗指南中英文对照,便于糖尿病专业英语的学习2011年ADA糖尿病... 笑话大全爆笑版 幽默笑话大全 全球冷笑话精选 104份文档 2014年驾照交规 ...
16 糖尿病天地?临床刊2011年1月第5卷第1期DiabetesWorld,Jan201l,Vol5,No.1 doi:10.3969/j.issn.1672~7851.2011.01.003 201 1年ADA糖尿病诊疗指南摘要...
Feb201l,Vol5,No.2 doi:10.3969/j.issn.1672—7851.2011.02.002 专家共识\_●—’、一一‘●--/ 201 1年ADA糖尿病诊疗指南摘要 美国糖尿病协会 血脂...
2011 版美国糖尿病学会(ADA)糖尿病诊疗指南 2011 年初,美国糖尿病学会(ADA)按照惯例再度更新了糖尿病 诊疗指南[Diabetes Care 2011, 34(Suppl 1): S1],为...
Jan 2011,Vol 5, No.1 doi:10.3969/j.issn.1672-7851.2011.01.003 2011年ADA糖尿病诊疗指南摘要美国糖尿病协会 糖尿病诊断标准● 糖化血红蛋白 A1C ≥ 6...
2011年ADA糖尿病诊疗标准 10页 2财富值喜欢此文档的还喜欢 2011版美国糖尿病学会(ADA... 3页 免费 2011年ADA糖尿病诊疗指南 12页 免费 2011年ADA糖尿病诊疗...
热门文档